Hudson Bay Capital Management
IBB icon

Hudson Bay Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Hudson Bay Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-120,000
Closed -$17.5M – 1000
2024
Q3 		$17.5M Buy
+120,000
New +$17.4M 0.07% 188

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hudson Bay Capital Management's IBB Position: Q3 2018 in Review

Hudson Bay Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 46,900 shares — an estimated $5.15M sold.

Hudson Bay Capital Management first reported a position in IBB in Q4 2015 and held it in 3 quarters. The position peaked at $5.15M in Q2 2018. 630 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

  • Hudson Bay Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 46,900 iShares Biotechnology ETF shares in Q3 2018, an estimated $5.15M.
  • Hudson Bay Capital Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 3 quarters.
  • Hudson Bay Capital Management's iShares Biotechnology ETF position peaked at $5.15M in Q2 2018.
  • 630 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Hudson Bay Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.